WuXi Biologics Named to Hang Seng Corporate Sustainability Benchmark Index
Reuters
Oct 22, 2025
WuXi Biologics Named to <a href="https://laohu8.com/S/HSNGF">Hang Seng</a> Corporate Sustainability Benchmark Index
WuXi Biologics (Cayman) Inc. announced its inclusion in the 2025 Hang Seng Corporate Sustainability Benchmark Index, marking it as the only pharmaceutical industry company selected for this listing. The company has also been previously included in the HSI ESG Index and the Hang Seng ESG 50 Index. The selection recognizes publicly listed companies with notable ESG performance, based on an annual sustainability assessment conducted by the Hong Kong Quality Assurance Agency. WuXi Biologics reports ongoing engagement with the United Nations Global Compact and the Pharmaceutical Supply Chain Initiative, and its greenhouse gas emissions-reduction targets have been approved by the Science Based Targets initiative. The company has received several sustainability ratings and recognitions from organizations including MSCI, EcoVadis, Dow Jones Sustainability Indices, CDP, Sustainalytics, FTSE4Good, and ISS ESG.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics (Cayman) Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN03088) on October 22, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.